BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 31365053)

  • 1. Cutting back malaria: CRISPR/Cas9 genome editing of Plasmodium.
    Lee MCS; Lindner SE; Lopez-Rubio JJ; Llinás M
    Brief Funct Genomics; 2019 Sep; 18(5):281-289. PubMed ID: 31365053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing Systems for Cas9 Expression in Toxoplasma gondii.
    Markus BM; Bell GW; Lorenzi HA; Lourido S
    mSphere; 2019 Jun; 4(3):. PubMed ID: 31243081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9 and genetic screens in malaria parasites: small genomes, big impact.
    Ishizaki T; Hernandez S; Paoletta MS; Sanderson T; Bushell ESC
    Biochem Soc Trans; 2022 Jun; 50(3):1069-1079. PubMed ID: 35621119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 Editing of the Plasmodium falciparum Genome.
    Adjalley S; Lee MCS
    Methods Mol Biol; 2022; 2470():221-239. PubMed ID: 35881349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity.
    Cui Z; Tian R; Huang Z; Jin Z; Li L; Liu J; Huang Z; Xie H; Liu D; Mo H; Zhou R; Lang B; Meng B; Weng H; Hu Z
    Nat Commun; 2022 Mar; 13(1):1425. PubMed ID: 35301321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome Editing Using CRISPR/Cas9 System in the Rice Blast Fungus.
    Arazoe T
    Methods Mol Biol; 2021; 2356():149-160. PubMed ID: 34236684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
    Vermersch E; Jouve C; Hulot JS
    Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9-Mediated Genome Editing of Trichoderma reesei.
    Zou G; Zhou Z
    Methods Mol Biol; 2021; 2234():87-98. PubMed ID: 33165782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical Control of Genome Editing by Photoactivatable Cas9.
    Otabe T; Nihongaki Y; Sato M
    Methods Mol Biol; 2021; 2312():225-233. PubMed ID: 34228293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guide RNA modification as a way to improve CRISPR/Cas9-based genome-editing systems.
    Filippova J; Matveeva A; Zhuravlev E; Stepanov G
    Biochimie; 2019 Dec; 167():49-60. PubMed ID: 31493470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulating CRISPR/Cas9 Function through Conditional Guide RNA Control.
    Brown W; Zhou W; Deiters A
    Chembiochem; 2021 Jan; 22(1):63-72. PubMed ID: 32833316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing.
    Finn JD; Smith AR; Patel MC; Shaw L; Youniss MR; van Heteren J; Dirstine T; Ciullo C; Lescarbeau R; Seitzer J; Shah RR; Shah A; Ling D; Growe J; Pink M; Rohde E; Wood KM; Salomon WE; Harrington WF; Dombrowski C; Strapps WR; Chang Y; Morrissey DV
    Cell Rep; 2018 Feb; 22(9):2227-2235. PubMed ID: 29490262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR deactivation in mammalian cells using photocleavable guide RNAs.
    Zou RS; Liu Y; Ha T
    STAR Protoc; 2021 Dec; 2(4):100909. PubMed ID: 34746867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9 in genome editing: Its function and medical applications.
    Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
    J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoscale metal-organic frameworks for the intracellular delivery of CRISPR/Cas9 genome editing machinery.
    Zheng Q; Li W; Mao L; Wang M
    Biomater Sci; 2021 Oct; 9(21):7024-7033. PubMed ID: 34378567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrypting the mechanistic basis of CRISPR/Cas9 protein.
    Panda G; Ray A
    Prog Biophys Mol Biol; 2022 Aug; 172():60-76. PubMed ID: 35577099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cas9 transgenic Plasmodium yoelii parasite for efficient gene editing.
    Qian P; Wang X; Yang Z; Li Z; Gao H; Su XZ; Cui H; Yuan J
    Mol Biochem Parasitol; 2018 Jun; 222():21-28. PubMed ID: 29684399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas9-Mediated Gene Silencing in Cultured Human Epithelia.
    Gago S; Overton NLD; Bowyer P
    Methods Mol Biol; 2021; 2260():37-47. PubMed ID: 33405030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.
    Shin HR; Kweon J; Kim Y
    Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cas9 exo-endonuclease eliminates chromosomal translocations during genome editing.
    Yin J; Lu R; Xin C; Wang Y; Ling X; Li D; Zhang W; Liu M; Xie W; Kong L; Si W; Wei P; Xiao B; Lee HY; Liu T; Hu J
    Nat Commun; 2022 Mar; 13(1):1204. PubMed ID: 35260581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.